AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
MGPI

MGP Ingredients Inc. (MGPI) fair value

Consumer Defensive · Beverages - Wineries & Distilleries · NASDAQ · United States
$15.73-3.20%
Market cap $348MNext earnings 2026-10-28Updated Oct 20, 2026
Add earnings to calendarGoogle
Our verdict
Trades 17% above our fair value
Price
$15.73
Model fair valueConfidence: good
$13.42
Model range
$6.72 to $19.16
Fair value $13.42
Price $15.73
2 models fit MGP Ingredients Inc. and they disagree: 0 of 2 land within 15% of the average.
Two or more of our models back this value.
Premium(i)Bronze46
Valued as a mature, profitable company: Discounted cash flow, P/E comparison, and Dividend discount.
ACCE opinionMGP Ingredients Inc. (MGPI)
Fair value (2 models)
$13.42
ACCE price target
$16.00
Rating
Overvalued
Horizon
12 months
Fair value published on 20 Oct 2026, 16:04 CEST; previously $12.79 since 16 Oct 2026, 00:00 CEST.
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Rating published on 20 Oct 2026, 16:04 CEST.
Price used: $15.73 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow and Dividend discount.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
17.2% above
-14.7% to fair value
ACCE score
35
out of 100
Analysts
80% buy
5 covering
P/E
0.0x
forward 6.8x
1-year return
-35.6%
Dividend yield
3.23%

MGP Ingredients Inc. in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

MGP Ingredients makes bourbon, rye and other whiskeys under brands such as Penelope and Pure Kentucky, and also sells distilled spirits and specialty wheat proteins and starches to food and beverage makers. The business has a durable edge in aged inventory: distillers cannot easily ramp barrel-aged whiskey, so supply is tight when demand returns. Revenue fell 14.5% over the last year as spirits demand softened and destocking hit the ingredients side, and the stock trades at about 6.8x forward earnings with a 14.8% operating margin, so the question is whether the trough is near. The company carries a negative return on equity of -33.8% and a 35/100 score, which argues for caution, but the depressed multiple leaves room for a recovery if whiskey inventory normalises and volumes stabilise. It is worth a deeper look mainly to test whether earnings have bottomed; the -14.5% revenue trend is the number to watch.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 3 flagsAI-assisted·How I use AI
  • high
    Net loss and negative ROE
    Net margin is -48.4% and ROE is -33.8%, so the company is losing money on its equity base despite a 14.8% operating margin. Earnings fell 17.7% YoY.
  • moderate
    Revenue declining sharply
    Revenue is down 14.5% YoY, well below the 6.3% five-year CAGR, which points to a recent break in trend rather than a cyclical blip.
  • moderate
    Insider selling without buying
    Insiders disclosed $1.08M in sales and $0.00M in purchases across the last 10 filings, with no offsetting buying.

AI research notes

AI-assisted·How I use AIWritten Oct 13, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Free cash flow over the last twelve months reached $76M, a strong cash return against a share price of $14.36.
  • Analysts put a mean price target of $26.80, which sits 86.6% above the current share price.
  • The latest quarter beat expectations, with earnings per share of 0.72 against 0.49 expected, a surprise of 46.9%.
Why it could disappoint
  • Revenue fell 14.5% year over year, well below its 5-year average growth of 6.3% per year.
  • Net margin is negative at -48.4%, and return on equity of -33.8% shows the business is losing money on shareholder capital.
  • Return on invested capital of -9.0% means the money tied up in the business is not earning a return.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Oct 28, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where MGPI's valuation models land
Price
$15.73
Model fair value
$13.42
Model range
$6.72 to $19.16
Fair value $13.42
Price $15.73
The price sits inside the model range.
Model
Fair value
Upside
Discounted cash flow
Dividend discount
P/E comparison
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish80% buy · 5 covering analysts
● Strong buy 4● Buy 0● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
+4.0%
1 month
+21.6%
3 months
-11.1%
6 months
-22.2%
YTD
-35.3%
1 year
-35.6%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
20 Oct 2026, 16:04 CESTRatingOvervaluedfirst publication$15.02
20 Oct 2026, 16:04 CESTFair value$13.42$12.79$15.02
16 Oct 2026, 00:00 CESTFair value$12.79$14.20$14.60
15 Oct 2026, 00:00 CESTACCE price target$16.00first publication$14.61
7 Oct 2026, 00:00 CESTFair value$14.20$14.36$12.77
26 Sept 2026, 00:00 CESTFair value$14.36$16.19$12.74
23 Sept 2026, 00:00 CESTFair value$16.19$16.86$13.39
11 Sept 2026, 00:00 CESTFair value$16.86$17.91$15.09
6 Sept 2026, 00:00 CESTFair value$17.91$20.20$16.40
4 Sept 2026, 00:00 CESTFair value$20.20$19.78$16.83

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full MGPI page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth7Value73Quality44Momentum17Total35
Valuation
Trailing P/E
0.0x
Forward P/E
6.8x
PEG
1.13
P/B
0.49x
EV / Revenue
1.3x
Book value/sh
$27.59
Enterprise value
$649M
Profitability
ROE
-33.8%
FCF yield
23.86%
ROIC
-9.0%
Health and risk
Debt / equity
0.37
Dividend yield
3.23%
Beta
0.48

Price

-35.3% · 1Y

Ask anything about MGPI

Answered from MGP Ingredients Inc. fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 100% of peers
low 0.0x0.0xhigh 371.4x
ROEbetter than 0% of peers
low -34%-34%high 10%
Div yieldbetter than 83% of peers
low 0.0%3.2%high 3.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
MGPI MGP Ingredients Inc.$15.73$1317% above--33.8%4435
MBWS.PA Marie Brizard Wine & Spirits SA€2.82€268% above34.3x3.9%4640
SNDL SNDL Inc. Common Shares$1.29----2.0%3931
LPE.PA Laurent-Perrier S.A.€78.20€11834% below9.1x7.7%7060
SBT.PA Oeneo SA€8.76€728% above20.8x8.4%6345
ALLAN.PA Lanson-BCC€25.70€5251% below10.7x4.3%5743
AGCC Agencia Comercial Spirits Ltd Class A Ordinary Shares$14.86--371.4x10.4%5046

Sector report card

Where MGPI ranks against its sector peers on each metric.

Computing percentiles…
  • Business Wire•Oct 15, 2026
    MGP Ingredients Announces Plans to Rebrand as Sempreon
  • Business Wire•Oct 14, 2026
    MGP Ingredients to Report Third Quarter 2026 Financial Results on Wednesday, October 28, 2026
  • Business Wire•Sep 10, 2026
    Penelope Bourbon Rolls Out Cigar Sessions: Chapter 2, Crafted in Partnership with Alec Bradley Cigars
5 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 15
8-KCurrent reportPeriod 2026-10-14
View on SEC →
Oct 1
Form 4Insider transactionPeriod 2026-10-01
View on SEC →
September 2026
Sep 18
Form 4Insider transactionPeriod 2026-09-16
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR